Zhangzhou Pientzehuang Pharmaceutical | 600436 - Gastos De Venta Y Administración





Gastos De Venta Y Administración Cambio Fecha
Akebia Therapeutics USD 23.53M 3.19M 2025-12
Alaunos Therapeutics USD 585K 84K 2025-09
Avita Medical AUD 19.03M 1.95M 2025-12
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Dianthus Therapeutics USD 6.57M 1.62M 2025-12
Ionis Pharmaceuticals USD 151M 21M 2026-03
IQVIA Holdings USD 468M 46M 2025-12
Jiangsu Hengrui CNY 2.81B 191.05M 2026-03
Kangmei Pharma CNY 274.41M 15.05M 2025-09
Moderna USD 173M 135M 2026-03
Revvity USD 251.73M 9.82M 2025-12
Sh Fosun Pharma CNY 3.27B 1.17B 2026-03
Tectonic Therapeutic USD 3.44M 1.52M 2025-12
Viatris USD 1.03B 144.1M 2025-12
Wuxi Apptec CNY 1.04B 261.09M 2025-12
Xeris Pharmaceuticals USD 42.64M 3.82M 2025-12
Zz Pientze Pharmaceu CNY 214.31M 42.4M 2026-03